Stockreport

Inhibikase Announces Expansion of Senior Leadership Team [Yahoo! Finance]

Inhibikase Therapeutics, Inc.  (IKT) 
PDF --- John Adams, PhD Appointed Chief Scientific Officer --- --- Vince Aurentz to join Inhibikase Board of Directors --- BOSTON, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Inh [Read more]